This article is more than 5 years old. Information may no longer be current.
Intraocular mirror telescope may aid patients with wet, dry AMD
Click Here to Manage Email Alerts
CHICAGO – A presenter here suggested a novel treatment for patients with all types of age-related macular degeneration.
“With the new intraocular mirror telescope, cataract surgeons can improve vision of AMD patients, treating both dry and wet type AMD… The aging baby boomers need an immediate help, which right now can be achieved by an implanted telescopic optical solution,” Isaac Lipshitz, MD, said at the American Society of Cataract and Refractive Surgery meeting.
The OriLens (OptoLight Vision Technology) can be used in phakic and pseudophakic eyes, as well as for other retinal diseases. The device has not yet attained approval from the US Food and Drug Administration, but according to Dr. Lipshitz, it has demonstrated impressive visual outcomes in numerous patients.
“It is simple and safe and can be performed by any cataract surgeon,” he said. “It is complimentary to other medical treatments and… [there are] no problems with compliance, as occurs with anti-VEGF.”
The intraocular mirror telescope may help roughly 80% of AMD patients, and while it magnifies only the image on the central retina, it does preserve at least some peripheral vision, Dr. Lipshitz said. The device uses reflective optics technology, is sulcus fixated over a regular intraocular lens and has a central thickness of 1.25 mm.
- Disclosure: Dr. Lipshitz is the inventor, shareholder and CEO of OptoLight Vision Technology.